TherapeuticsMD (TXMD) Dividends payables (2010 - 2013)

TherapeuticsMD's (TXMD) quarterly Dividends payables came in at $41359.0 in Q3 2013, little changed quarter-over-quarter from $41359.0 in Q2 2013.

Analysis

TherapeuticsMD (TXMD) Dividends payables (2010 - 2013) Analysis & Trends

TherapeuticsMD (TXMD) has reported Dividends payables for 4 consecutive years, with $41359.0 the latest figure, recorded in Q3 2013.

For the quarter ending Q3 2013, Dividends payables changed N/A year-over-year to $41359.0; the trailing twelve-month figure through Sep 2013 stood at $41359.0 (changed N/A YoY), and the FY2012 full-year result was $41359.0, changed N/A from the prior year.
Dividends payables was little changed at $41359.0 in Q3 2013 per TXMD's latest filing, from $41359.0 in the prior quarter.
Across five years, Dividends payables topped out at $41359.0 in Q4 2010 and bottomed at $41359.0 in Q4 2010.
Historically, Dividends payables has averaged $41359.0 across 4 years, with a median of $41359.0 in 2010.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Dividends payables (Qtr)
1	Johnson & Johnson	650.65 Bn	629.89 Bn	17.26 Bn	-
2	AbbVie	466.34 Bn	459.82 Bn	12.70 Bn	-
3	Merck	362.11 Bn	355.02 Bn	12.21 Bn	2.13 Bn
4	Novartis Ag	267.81 Bn	260.52 Bn	11.24 Bn	-
5	Pfizer	157.31 Bn	145.91 Bn	10.94 Bn	2.45 Bn
6	Bristol Myers Squibb	128.75 Bn	117.69 Bn	9.25 Bn	-
7	Sanofi	51.80 Bn	44.84 Bn	10.79 Bn	-
8	Revolution Medicines	40.91 Bn	40.91 Bn	-	-
9	BeOne Medicines	39.65 Bn	34.55 Bn	1.53 Bn	-
10	TherapeuticsMD	25.35 Mn	16.16 Mn	-	-

Historic Data

Download Data